+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nicotinamide Adenine Dinucleotide Products Market Forecast to 2033- Product Image
Nicotinamide Adenine Dinucleotide Products Market Forecast to 2033- Product Image
New

Nicotinamide Adenine Dinucleotide Products Market Forecast to 2033

  • PDF Icon

    Report

  • 109 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189441
REQUEST CUSTOMIZATION
Description Jump to:
The global nicotinamide adenine dinucleotide products market size was valued at USD 3.45 billion in 2024 and is expected to reach USD 12.18 billion by 2033, growing at a CAGR of 15.1% from 2025 to 2033. The nicotinamide adenine dinucleotide (NAD) products industry is driven by increasing awareness of its role in cellular energy production, DNA repair, and healthy aging.

Consumers are seeking supplements that support vitality, cognitive function, and metabolic health, especially as interest in longevity and preventive wellness grows. Additionally, ongoing research linking NAD levels to age-related conditions has further fueled demand in the nutraceutical and wellness markets.

The popularity of NAD-boosting supplements like NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) has increased, driven by interest in healthy aging and cognitive support. Brands such as Tru Niagen and Elysium Health have capitalized on this trend, offering products that claim to enhance energy, focus, and resilience against age-related decline.

NAD products are also seeing wider use beyond supplements, appearing in IV therapy, skincare, and functional beverages, making them more accessible and appealing to a broader audience. As clinical research and consumer demand continue to grow, NAD is becoming a key ingredient in the evolving wellness and anti-aging space. For instance, in May 2025, Eden, a leading metabolic health platform, launched U.S.-wide access to a prescription-only NAD+ 10% Face Cream through its telehealth service.

The NAD products industry is expanding well beyond traditional oral supplements, with brands exploring new delivery formats to improve efficacy, user experience, and market appeal. While capsules and tablets containing precursors like Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN) remain the most common format, newer options such as liposomal formulations, sustained-release tablets, and sublingual powders are gaining popularity for their potential to enhance bioavailability. These innovations not only cater to consumer demand for more effective dosing but also allow brands to differentiate in a crowded market.

For instance, in January 2025, Renue by Science introduced a new skincare line called Renue Blue, which focuses on skin wellness and longevity through the use of liposomal NAD (Nicotinamide Adenine Dinucleotide). The product line aims to leverage the benefits of NAD, a coenzyme crucial for cellular functions, in a topical format to promote skin health. The liposomal delivery system is designed to enhance the absorption and effectiveness of NAD in the skin.

Nicotinamide Adenine Dinucleotide Products Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global nicotinamide adenine dinucleotide products market report on the basis of product, distribution channel, and region.

Product Outlook (Revenue, USD Million, 2021-2033)

  • Oral Supplements
  • Topical Products
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Hypermarkets & Supermarkets
  • Pharmacies & Drug Stores
  • Online
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Materials & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product Outlook
2.3. Distribution Channel Outlook
2.4. Regional Outlook
2.5. Competitive Landscape Snapshot
Chapter 3. Nicotinamide Adenine Dinucleotide (NAD) Products Market Variables and Trends
3.1. Market Introduction
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Trends & Outlook
3.2.2. Retail/Sales Channel Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies
Chapter 4. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Consumer Behavior Analysis
4.1. Demographic Analysis
4.2. Consumer Trends & Preferences
4.3. Factors Affecting Buying Decisions
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
Chapter 5. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Product Estimates & Trend Analysis
5.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, by Product: Key Takeaways
5.2. Product Movement Analysis & Market Share, 2024 & 2033
5.3. Market Estimates & Forecasts by Product, 2021-2033 (USD Million)
5.3.1. Oral Supplements
5.3.1.1. Market estimates and forecast, 2021-2033 (USD Million)
5.3.1.1.1. Capsules/Tablets
5.3.1.1.1.1. Market estimates and forecast, 2021-2033 (USD Million)
5.3.1.1.2. Powders
5.3.1.1.2.1. Market estimates and forecast, 2021-2033 (USD Million)
5.3.1.1.3. Energy Drinks
5.3.1.1.3.1. Market estimates and forecast, 2021-2033 (USD Million)
5.3.2. Topical Products
5.3.2.1. Market estimates and forecast, 2021-2033 (USD Million)
5.3.2.1.1. Creams & Serums
5.3.2.1.1.1. Market estimates and forecast, 2021-2033 (USD Million)
5.3.2.1.2. Eye Cream & Lip Balms
5.3.2.1.2.1. Market estimates and forecast, 2021-2033 (USD Million)
5.3.3. Others
5.3.3.1. Market estimates and forecast, 2021-2033 (USD Million)
Chapter 6. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Distribution Channel Estimates & Trend Analysis
6.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, by Distribution Channel: Key Takeaways
6.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2033
6.3. Market Estimates & Forecasts, by Distribution Channel, 2021-2033 (USD Million)
6.3.1. Hypermarkets & Supermarkets
6.3.1.1. Market estimates and forecast, 2021-2033 (USD Million)
6.3.2. Pharmacies & Drug Stores
6.3.2.1. Market estimates and forecast, 2021-2033 (USD Million)
6.3.3. Online
6.3.3.1. Market estimates and forecast, 2021-2033 (USD Million)
6.3.4. Others
6.3.4.1. Market estimates and forecast, 2021-2033 (USD Million)
Chapter 7. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2024 & 2033
7.2. North America
7.2.1. U.S.
7.2.1.1. Key country dynamics
7.2.1.2. Market estimates and forecast, 2021-2033 (USD Million)
7.2.2. Canada
7.2.2.1. Key country dynamics
7.2.2.2. Market estimates and forecast, 2021-2033 (USD Million)
7.2.3. Mexico
7.2.3.1. Key country dynamics
7.2.3.2. Market estimates and forecast, 2021-2033 (USD Million)
7.3. Europe
7.3.1. U.K.
7.3.1.1. Key country dynamics
7.3.1.2. Market estimates and forecast, 2021-2033 (USD Million)
7.3.2. Germany
7.3.2.1. Key country dynamics
7.3.2.2. Key country dynamics
7.3.2.3.Market estimates and forecast, 2021-2033 (USD Million)
7.3.3. France
7.3.3.1. Key country dynamics
7.3.3.2. Market estimates and forecast, 2021-2033 (USD Million)
7.3.4. Italy
7.3.4.1. Key country dynamics
7.3.4.2. Market estimates and forecast, 2021-2033 (USD Million)
7.3.5. Spain
7.3.5.1. Key country dynamics
7.3.5.2. Market estimates and forecast, 2021-2033 (USD Million)
7.4. Asia-Pacific
7.4.1. China
7.4.1.1. Key country dynamics
7.4.1.2. Market estimates and forecast, 2021-2033 (USD Million)
7.4.2. India
7.4.2.1. Key country dynamics
7.4.2.2. Market estimates and forecast, 2021-2033 (USD Million)
7.4.3. Japan
7.4.3.1. Key country dynamics
7.4.3.2. Market estimates and forecast, 2021-2033 (USD Million)
7.4.4. Australia & New Zealand
7.4.4.1. Key country dynamics
7.4.4.2. Market estimates and forecast, 2021-2033 (USD Million)
7.4.5. Taiwan
7.4.5.1. Key country dynamics
7.4.5.2. Market estimates and forecast, 2021-2033 (USD Million)
7.4.6. South Korea
7.4.6.1. Key country dynamics
7.4.6.2. Market estimates and forecast, 2021-2033 (USD Million)
7.5. Central & South America
7.5.1. Brazil
7.5.1.1. Key country dynamics
7.5.1.2. Market estimates and forecast, 2021-2033 (USD Million)
7.6. Middle East & Africa
7.6.1. UAE
7.6.1.1. Key country dynamics
7.6.1.2. Market estimates and forecast, 2021-2033 (USD Million)
Chapter 8. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Competitive Analysis
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2024 (%)
8.7. Company Heat Map Analysis, 2024
8.8. Strategy Mapping
8.9. Company Profiles
8.9.1. Core Med Science
8.9.1.1. Company Overview
8.9.1.2. Financial Performance
8.9.1.3. Product Portfolios
8.9.1.4. Strategic Initiatives
8.9.2. Niagen Bioscience, Inc.
8.9.2.1. Company Overview
8.9.2.2. Financial Performance
8.9.2.3. Product Portfolios
8.9.2.4. Strategic Initiatives
8.9.3. Elysium Health
8.9.3.1. Company Overview
8.9.3.2. Financial Performance
8.9.3.3. Product Portfolios
8.9.3.4. Strategic Initiatives
8.9.4. Thorne
8.9.4.1. Company Overview
8.9.4.2. Financial Performance
8.9.4.3. Product Portfolios
8.9.4.4. Strategic Initiatives
8.9.5. Cata-Kor NAD
8.9.5.1. Company Overview
8.9.5.2. Financial Performance
8.9.5.3. Product Portfolios
8.9.5.4. Strategic Initiatives
8.9.6. Life Extension
8.9.6.1. Company Overview
8.9.6.2. Financial Performance
8.9.6.3. Product Portfolios
8.9.6.4. Strategic Initiatives
8.9.7. Wonderfeel
8.9.7.1. Company Overview
8.9.7.2. Financial Performance
8.9.7.3. Product Portfolios
8.9.7.4. Strategic Initiatives
8.9.8. Nutricost
8.9.8.1. Company Overview
8.9.8.2. Financial Performance
8.9.8.3. Product Portfolios
8.9.8.4. Strategic Initiatives
8.9.9. RENUE bY SCIENCE, Inc.
8.9.9.1. Company Overview
8.9.9.2. Financial Performance
8.9.9.3. Product Portfolios
8.9.9.4. Strategic Initiatives
8.9.10. Codeage LLC
8.9.10.1. Company Overview
8.9.10.2. Financial Performance
8.9.10.3. Product Portfolios
8.9.10.4. Strategic Initiatives
8.9.11. HPN SUPPLEMENTS
8.9.11.1. Company Overview
8.9.11.2. Financial Performance
8.9.11.3. Product Portfolios
8.9.11.4. Strategic Initiatives
List of Tables
Table 1 Global nicotinamide adenine dinucleotide (NAD) products market - Key market driver analysis
Table 2 Global nicotinamide adenine dinucleotide (NAD) products market - Key market restraint analysis
Table 3 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by product (USD Million)
Table 4 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 5 U.S macro-economic outlay
Table 6 U.S nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 7 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 8 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 9 Canada macro-economic outlay
Table 10 Canada nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 11 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 12 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 13 Mexico macro-economic outlay
Table 14 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 15 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 16 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 17 U.K macro-economic outlay
Table 18 U.K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 19 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 20 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 21 Germany macro-economic outlay
Table 22 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 23 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 24 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 25 France macro-economic outlay
Table 26 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 27 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 28 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 29 Italy macro-economic outlay
Table 30 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 31 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 32 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 33 Spain macro-economic outlay
Table 34 Spain nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 35 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 36 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 37 China macro-economic outlay
Table 38 China nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 39 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 40 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 41 India macro-economic outlay
Table 42 India nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 43 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 44 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 45 Japan macro-economic outlay
Table 46 Japan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 47 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 48 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 49 Australia & New Zealand macro-economic outlay
Table 50 Australia & New Zealand Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 51 Taiwan macro-economic outlay
Table 52 Taiwan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 53 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 54 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 55 South Korea macro-economic outlay
Table 56 South Korea Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 57 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 58 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 59 Brazil macro-economic outlay
Table 60 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 61 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 62 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 63 UAE macro-economic outlay
Table 64 UAE nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Table 65 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
Table 66 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
Table 67 Recent developments & impact analysis by key market participants
Table 68 Company market share, 2024
Table 69 Company heat map analysis
Table 70 Companies undergoing key strategies
List of Figures
Figure 1 Global Nicotinamide Adenine Dinucleotide (NAD) Products Market Segmentation
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Primary research approaches
Figure 5 Primary research process
Figure 6 Market snapshot
Figure 7 Product snapshot
Figure 8 Distribution Channel snapshot
Figure 9 Regional snapshot
Figure 10 Competitive landscape snapshot
Figure 11 Global nicotinamide adenine dinucleotide (NAD) products market size (USD Million)
Figure 12 Global nicotinamide adenine dinucleotide (NAD) products market size, 2021 to 2033 (USD Million)
Figure 13 Global nicotinamide adenine dinucleotide (NAD) products market: Penetration & growth prospect mapping
Figure 14 Global nicotinamide adenine dinucleotide (NAD) products market: Value chain analysis
Figure 15 Global nicotinamide adenine dinucleotide (NAD) products market: Profit margin analysis
Figure 16 Global nicotinamide adenine dinucleotide (NAD) products market: Market dynamics
Figure 17 Global nicotinamide adenine dinucleotide (NAD) products market: Porter's five forces analysis
Figure 18 Factors influencing buying decisions for nicotinamide adenine dinucleotide (NAD) products
Figure 19 Global nicotinamide adenine dinucleotide (NAD) products market: Product Movement Analysis, 2024 & 2033 (%)
Figure 20 Oral Supplements market estimates and forecast, 2021-2033 (USD Million)
Figure 21 Capsules/Tablets market estimates and forecast, 2021-2033 (USD Million)
Figure 22 Powders market estimates and forecast, 2021-2033 (USD Million)
Figure 23 Energy Drinks market estimates and forecast, 2021-2033 (USD Million)
Figure 24 Topical Products market estimates and forecast, 2021-2033 (USD Million)
Figure 25 Creams & Serums market estimates and forecast, 2021-2033 (USD Million)
Figure 26 Eye Cream & Lip Balms market estimates and forecast, 2021-2033 (USD Million)
Figure 27 Others market estimates and forecast, 2021-2033 (USD Million)
Figure 28 Global nicotinamide adenine dinucleotide (NAD) products market: Distribution Channel Movement Analysis, 2024 & 2033 (%)
Figure 29 Hypermarkets & Supermarkets nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 30 Pharmacies & Drug Stores nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 31 Online nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 32 Others nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 33 Global nicotinamide adenine dinucleotide (NAD) products market: Regional outlook, 2024 & 2033 (USD Million)
Figure 34 Regional marketplace: Key takeaways
Figure 35 North America market estimates and forecast, 2021-2033 (USD Million)
Figure 36 U S market estimates and forecast, 2021-2033 (USD Million)
Figure 37 Canada market estimates and forecast, 2021-2033 (USD Million)
Figure 38 Mexico market estimates and forecast, 2021-2033 (USD Million)
Figure 39 Europe nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 40 U K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 41 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 42 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 43 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 44 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021-2033 (USD Million)
Figure 45 Spain nicotinamide adenine dinucleotide (NAD) products market estimates, 2021-2033 (USD Million)
Figure 46 China market estimates and forecast, 2021-2033 (USD Million)
Figure 47 India market estimates and forecast, 2021-2033 (USD Million)
Figure 48 Japan market estimates and forecast, 2021-2033 (USD Million)
Figure 49 Australia & New Zealand market estimates and forecast, 2021-2033 (USD Million)
Figure 50 Taiwan market estimates and forecast, 2021-2033 (USD Million)
Figure 51 South Korea market estimates and forecast, 2021-2033 (USD Million)
Figure 52 Brazil market estimates and forecast, 2021-2033 (USD Million)
Figure 53 UAE market estimates and forecast, 2021-2033 (USD Million)
Figure 54 Key company categorization
Figure 55 Company market share analysis, 2024
Figure 56 Strategic framework of nicotinamide adenine dinucleotide (NAD) products market

Companies Mentioned

The companies profiled in this Nicotinamide Adenine Dinucleotide Products market report include:
  • Niagen Bioscience, Inc.
  • Elysium Health
  • Thorne
  • Cata-Kor NAD
  • Life Extension
  • Wonderfeel
  • Nutricost
  • RENUE BY SCIENCE, Inc.
  • Codeage LLC
  • HPN SUPPLEMENTS
  • Core Med Science

Table Information

Report AttributeDetails
No. of Pages109
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 3.45 Billion
Forecasted Market Value ( USD ) by 2033 $ 12.18 Billion
Compound Annual Growth Rate15.1%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Nicotinamide Adenine Dinucleotide - Global Strategic Business Report - Product Image

Nicotinamide Adenine Dinucleotide - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Beta-Nicotinamide Adenine Dinucleotide Disodium Salt Market - Global Forecast 2025-2030 - Product Image

Beta-Nicotinamide Adenine Dinucleotide Disodium Salt Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Nicotinamide Hypoxanthine Dinucleotide (CAS 42934-87-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Nicotinamide Hypoxanthine Dinucleotide (CAS 42934-87-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Nicotinamide-8-Bromoadenine Dinucleotide (CAS 52977-37-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Nicotinamide-8-Bromoadenine Dinucleotide (CAS 52977-37-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Flavine Adenine Dinucleotide (CAS 146-14-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Flavine Adenine Dinucleotide (CAS 146-14-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.